Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation

被引：9

作者：

Amo, Y ^{[1
]}

Masuzawa, M ^{[1
]}

Hamada, Y ^{[1
]}

Katsuoka, K ^{[1
]}

机构：

[1] Kitasato Univ, Sch Med, Dept Dermatol, Kanagawa 2288555, Japan

来源：

ACTA DERMATO-VENEREOLOGICA | 2002年 / 82卷 / 05期

关键词：

D O I：

10.1080/000155502320624122

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：373 / 374

页数：2

共 9 条

[1] Serum levels of vascular endothelial growth factor in a haemangiosarcoma patient with a newly typed p53 gene point mutation [J].

Amo, Y ;

Masuzawa, M ;

Hamada, Y ;

Takasu, H ;

Fujimura, T ;

Katsuoka, K ;

Tamauchi, H .

BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) :1118-1119

[2] Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS) [J].

Amo, Y ;

Masuzawa, M ;

Hamada, Y ;

Katsuoka, K .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2001, 293 (06) :296-301

[3]

Hashimoto M, 1995, LAB INVEST, V73, P859

[4] P53 MUTATIONS IN HUMAN CANCERS [J].

HOLLSTEIN, M ;

SIDRANSKY, D ;

VOGELSTEIN, B ;

HARRIS, CC .

SCIENCE, 1991, 253 (5015) :49-53

[5] Vascular endothelial growth factor vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma [J].

Masood, R ;

Cai, J ;

Zheng, T ;

Smith, DL ;

Naidu, Y ;

Gill, PS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (03) :979-984

[6]

Masuzawa M, 1999, INT J CANCER, V81, P305, DOI 10.1002/(SICI)1097-0215(19990412)81:2<305::AID-IJC22>3.0.CO

[7]

2-Z

[8]

Naka N, 1997, INT J CANCER, V71, P952, DOI 10.1002/(SICI)1097-0215(19970611)71:6<952::AID-IJC7>3.0.CO

[9]

2-X

← 1 →